These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 16353168

  • 1. PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma.
    Buttitta F, Felicioni L, Barassi F, Martella C, Paolizzi D, Fresu G, Salvatore S, Cuccurullo F, Mezzetti A, Campani D, Marchetti A.
    J Pathol; 2006 Feb; 208(3):350-5. PubMed ID: 16353168
    [Abstract] [Full Text] [Related]

  • 2. p53 mutations and histological type of invasive breast carcinoma.
    Marchetti A, Buttitta F, Pellegrini S, Campani D, Diella F, Cecchetti D, Callahan R, Bistocchi M.
    Cancer Res; 1993 Oct 01; 53(19):4665-9. PubMed ID: 8402644
    [Abstract] [Full Text] [Related]

  • 3. Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women.
    Maruyama N, Miyoshi Y, Taguchi T, Tamaki Y, Monden M, Noguchi S.
    Clin Cancer Res; 2007 Jan 15; 13(2 Pt 1):408-14. PubMed ID: 17202311
    [Abstract] [Full Text] [Related]

  • 4. Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas.
    Barbareschi M, Buttitta F, Felicioni L, Cotrupi S, Barassi F, Del Grammastro M, Ferro A, Dalla Palma P, Galligioni E, Marchetti A.
    Clin Cancer Res; 2007 Oct 15; 13(20):6064-9. PubMed ID: 17947469
    [Abstract] [Full Text] [Related]

  • 5. PIK3CA mutations mostly begin to develop in ductal carcinoma of the breast.
    Li H, Zhu R, Wang L, Zhu T, Li Q, Chen Q, Wang H, Zhu H.
    Exp Mol Pathol; 2010 Feb 15; 88(1):150-5. PubMed ID: 19818761
    [Abstract] [Full Text] [Related]

  • 6. PIK3CA gene mutations in breast carcinoma in Malaysian patients.
    Ching-Shian Leong V, Jabal MF, Leong PP, Abdullah MA, Gul YA, Seow HF.
    Cancer Genet Cytogenet; 2008 Dec 15; 187(2):74-9. PubMed ID: 19027487
    [Abstract] [Full Text] [Related]

  • 7. Frequent mutation of the PIK3CA gene in ovarian and breast cancers.
    Levine DA, Bogomolniy F, Yee CJ, Lash A, Barakat RR, Borgen PI, Boyd J.
    Clin Cancer Res; 2005 Apr 15; 11(8):2875-8. PubMed ID: 15837735
    [Abstract] [Full Text] [Related]

  • 8. PIK3CA exon 20 mutation is independently associated with a poor prognosis in breast cancer patients.
    Lai YL, Mau BL, Cheng WH, Chen HM, Chiu HH, Tzen CY.
    Ann Surg Oncol; 2008 Apr 15; 15(4):1064-9. PubMed ID: 18183466
    [Abstract] [Full Text] [Related]

  • 9. Mutation of the PIK3CA gene in ovarian and breast cancer.
    Campbell IG, Russell SE, Choong DY, Montgomery KG, Ciavarella ML, Hooi CS, Cristiano BE, Pearson RB, Phillips WA.
    Cancer Res; 2004 Nov 01; 64(21):7678-81. PubMed ID: 15520168
    [Abstract] [Full Text] [Related]

  • 10. Enhanced mRNA expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in breast carcinomas is correlated with adverse prognosis.
    Nakopoulou L, Giannopoulou I, Stefanaki K, Panayotopoulou E, Tsirmpa I, Alexandrou P, Mavrommatis J, Katsarou S, Davaris P.
    J Pathol; 2002 Jul 01; 197(3):307-13. PubMed ID: 12115876
    [Abstract] [Full Text] [Related]

  • 11. PIK3CA mutations in breast cancer are associated with poor outcome.
    Li SY, Rong M, Grieu F, Iacopetta B.
    Breast Cancer Res Treat; 2006 Mar 01; 96(1):91-5. PubMed ID: 16317585
    [Abstract] [Full Text] [Related]

  • 12. p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data.
    O'Malley FP, Vnencak-Jones CL, Dupont WD, Parl F, Manning S, Page DL.
    Lab Invest; 1994 Jul 01; 71(1):67-72. PubMed ID: 8041120
    [Abstract] [Full Text] [Related]

  • 13. PIK3CA mutations in advanced ovarian carcinomas.
    Wang Y, Helland A, Holm R, Kristensen GB, Børresen-Dale AL.
    Hum Mutat; 2005 Mar 01; 25(3):322. PubMed ID: 15712344
    [Abstract] [Full Text] [Related]

  • 14. PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas.
    Lee JW, Soung YH, Kim SY, Lee HW, Park WS, Nam SW, Kim SH, Lee JY, Yoo NJ, Lee SH.
    Oncogene; 2005 Feb 17; 24(8):1477-80. PubMed ID: 15608678
    [Abstract] [Full Text] [Related]

  • 15. Diffuse growth pattern affects E-cadherin expression in invasive breast cancer.
    Brinck U, Jacobs S, Neuss M, Tory K, Rath W, Kulle B, Füzesi L.
    Anticancer Res; 2004 Feb 17; 24(4):2237-42. PubMed ID: 15330167
    [Abstract] [Full Text] [Related]

  • 16. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR, Abd-Elwahed SR, Abdulwahed AR.
    Cell Biol Int; 2008 Jun 17; 32(6):698-707. PubMed ID: 18296077
    [Abstract] [Full Text] [Related]

  • 17. Mucinous breast carcinomas lack PIK3CA and AKT1 mutations.
    Kehr EL, Jorns JM, Ang D, Warrick A, Neff T, Degnin M, Lewis R, Beadling C, Corless CL, Troxell ML.
    Hum Pathol; 2012 Dec 17; 43(12):2207-12. PubMed ID: 22705004
    [Abstract] [Full Text] [Related]

  • 18. High frequency of G/C transversion on p53 gene alterations in breast cancers from Taiwan.
    Chen FM, Hou MF, Wang JY, Chen TC, Chen DC, Huang SY, Chung YS, Lin SR.
    Cancer Lett; 2004 Apr 15; 207(1):59-67. PubMed ID: 15050734
    [Abstract] [Full Text] [Related]

  • 19. Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institution.
    Intra M, Rotmensz N, Viale G, Mariani L, Bonanni B, Mastropasqua MG, Galimberti V, Gennari R, Veronesi P, Colleoni M, Tousimis E, Galli A, Goldhirsch A, Veronesi U.
    Cancer; 2004 Sep 01; 101(5):905-12. PubMed ID: 15329896
    [Abstract] [Full Text] [Related]

  • 20. High frequency of somatic missense mutation of BRCA2 in female breast cancer from Taiwan.
    Chen FM, Hou MF, Chang MY, Wang JY, Hsieh JS, Ou-Yang F, Huang TJ, Lin SR.
    Cancer Lett; 2005 Apr 08; 220(2):177-84. PubMed ID: 15766593
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.